Alzheimer s & Dementia, Journal Year: 2024, Volume and Issue: 21(1)
Published: Dec. 28, 2024
The Alzheimer's Association convened a Diagnostic Evaluation, Testing, Counseling and Disclosure Clinical Practice Guideline workgroup to help combat the major global health challenges surrounding timely detection, accurate diagnosis, appropriate disclosure of mild cognitive impairment (MCI) or dementia due disease (AD) other diseases that cause these types cognitive-behavioral disorders. newly published clinical practice guidelines are proposed as structured approach evaluation. purpose present article is provide perspective on use neuropsychology within new framework outlined under Suspected Disease Related Disorders (DETeCD-ADRD) recommendations for primary care specialty care. Neuropsychological evaluation critical component in supporting early diagnosis staging, characterizing profile, assessing trajectory over time, providing specifically tailored individual their team. HIGHLIGHTS: Reviews neuropsychological (DETeCD-ADRD). Examines utility assessment (ADRD). Supports basis
Language: Английский